Summary:
This will be a 12-week, multicenter, randomized, double-blind trial evaluating the efficacy, safety, and tolerability of fixed-dose brexpiprazole + sertraline combination treatment in adult subjects with post-traumatic stress disorder.
Qualified Participants Must:
• Aged 18 to 65 years
•
Discontinue any prohibited medications
•
Read and understand the Informed Consent prior to enrollment
Qualified Participants May Receive:
Compensation for completion of study visits and travel.